UFPTUFP Technologies, Inc.

Filed with the SEC on November 3, 2026 | Form 8-K (Items 2.02, 9.01)

Metric	Q2 FY2026
Revenue	$299,324,000
Operating Income	$47,455,000
Net Income	$17,184,000
Basic EPS	$4.46
Diluted EPS	$4.42

Current Price: $317.68 | Today's Change: +13.33%

---

What Happened

UFP Technologies, Inc. filed an 8-K with the SEC on November 3, 2026, disclosing its Q2 FY2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The company reported revenue of $299.3 million, operating income of $47.5 million, and net income of $17.2 million for the quarter. Diluted earnings per share came in at $4.42 and basic EPS at $4.46, reflecting the period's profitability on a per-share basis.

Why It Matters

The market's response has been immediate and pronounced — UFPT shares are up 13.33% on the day, trading at $317.68, suggesting the quarterly results materially exceeded investor expectations heading into this disclosure. The operating income figure of $47.5 million represents a strong margin relative to the $299.3 million revenue base, pointing to disciplined cost management and pricing power. For investors, the key near-term question is whether this level of revenue and profitability is sustainable or accelerating — particularly given that UFP Technologies serves specialized end markets including medical packaging and advanced composites, where order visibility can shift quickly. This follows our existing StockWatch initiating coverage published on September 24, 2026, and the sharp post-earnings price move is directly relevant to that prior analytical context.

Analysis

The combination of a $299.3 million top line and $47.5 million in operating income signals that UFP Technologies is operating with meaningful operating leverage at current revenue levels. Net income of $17.2 million, while lower than operating income, reflects items below the operating line that investors will want to scrutinize in the full financial statements attached under Item 9.01. The gap between operating income and net income — roughly $30 million — warrants attention and may reflect interest expense, tax provisions, or non-operating items not broken out in the structured XBRL data provided here.

The 13% single-day stock move is a signal that the market was positioned more cautiously than the results warranted. Key things to watch going forward include: whether revenue growth is organic or acquisition-driven, how margins trend in subsequent quarters, and any forward guidance language included in the company's earnings press release or supplemental materials filed with this 8-K. UFP Technologies' exposure to medical device and specialty packaging end markets means revenue can be lumpy, and investors should monitor customer concentration disclosures in the full filing.

---

Disclaimer

This report is a news and informational summary based solely on the structured financial data extracted from UFP Technologies' SEC filing dated November 3, 2026, and is not investment advice. No rating or price target is issued in this report. Readers should review the full SEC filing and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on UFPT, published 2026-09-24. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-03. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/914156/000162828026069511/ufpt-20261103.htm